Linda Van Eldik; Sanders-Brown Center on Aging at the University of Kentucky (VIDEO)

University of Kentucky

Caption

Linda Van Eldik is beginning in-human testing of a drug candidate she developed from scratch, supported by funding from the NIH and the Alzheimer's Drug Discovery Foundation. The drug targets dysregulated inflammation in the brain -- a departure from the popular "Amyloid Theory."

Credit

University of Kentucky Office of Research Communications

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.